Premium
Enanta Pharmaceuticals Inc (ENTA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company’s product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV... Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company’s product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.845 | -14.0571428571 | 13.125 | 13.31 | 11.17 | 222257 | 11.73207858 | CS |
| 4 | -4.27 | -27.459807074 | 15.55 | 15.8899 | 11.17 | 227074 | 13.29701571 | CS |
| 12 | -1.59 | -12.3543123543 | 12.87 | 15.93 | 11.17 | 167761 | 13.49869344 | CS |
| 26 | -3.47 | -23.5254237288 | 14.75 | 17.15 | 11.17 | 220047 | 13.99562583 | CS |
| 52 | 3.72 | 49.2063492063 | 7.56 | 17.15 | 6.435 | 340721 | 12.30009299 | CS |
| 156 | -14.99 | -57.0612866388 | 26.27 | 26.91 | 4.09 | 303586 | 11.31069266 | CS |
| 260 | -37.96 | -77.0917952884 | 49.24 | 102 | 4.09 | 262453 | 24.63357324 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
